Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2007, p. 1512-1514, Vol. 51, No. 4
0066-4804/07/$08.00+0 doi:10.1128/AAC.00959-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Creighton University School of Medicine, Department of Medical Microbiology and Immunology, Center for Research in Anti-Infectives and Biotechnology, 2500 California Plaza, Omaha, Nebraska 68178
Received 2 August 2006/ Returned for modification 7 September 2006/ Accepted 27 December 2006
DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.
Published ahead of print on 12 January 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»